Hygiaso Ltd
Hygiaso was founded in 2022 to bring to life a novel platform centered around the personal health data of every citizen. We believe that in democratic society the individual must be informed about their health and autonomous in their decision as to what personal data they share with whom and for what purpose.
We participate in a public private consortium which submitted a proposal to the Horizon Europe Innovative Health Initiative together with multinational companies in the Pharma and Medtech sector, as well as academic groups, who share our believe that enabling citizen to freely say yes or no to an informed and specific request for data use is the key to unlock and join health data for research and development across the public and private sector.
We are going to raise seed finance to accelerate the development, in parallel to funding through the consortium starting in 2023.
We advise and support our clients in navigating and digitally transforming in the fast evolving domain of technology, data, privacy, regulation and compliance in the health care sector. We provide a structured approach using agile methodology and setting clear goals.
Who We Are
Dominik Geller
Founder
- Ing. ETH IT and Computer Science, EMBL-HSG EU and International Business Law
- 20+ years multidisciplinary international leadership in Pharma/Diagnostic, Roche & Sanofi
- Digital and data governance, risk and compliance, privacy technology and secondary use of data, transformation and change management
- Impact assessment, advocacy on EU data law and European Health Data Space, AI, strategy response
- Strategy, technology evaluation and solutions to seize opportunities, designed to sustain in regulatory conformance
Ralph C. Schimmer
Medical Advisor and designated Board Member
- MD, MBA
- 20+ years Pharma and Diagnostics experience at senior leadership levels in clinical development, medical affairs and access, safety risk management, marketing and sales
- Extensive disease area expertise
- Former Chief Medical Officer and SVP at Roche
- Professor of Medicine at University of Zurich
Riddhiman Das
Advisor and designated Board Member
- Master Computer Science and Electrical Engineering, University of Missouri, Kansas City
- Founder and CEO of TripleBlind
- Formerly venture capital technology investments at Ant Financial (Alibaba Group, for Alipay) following successful development and exit of Biometric EyeVerify
- Serial entrepreneur and innovator, developer, architect and CTO in software and product development. 2013 Champions of Change from President Obama
Through our network, we are assembling a team of highly qualified experts to join us in supporting you.